Among GLP-1 users, about 25% lacked a diabetes diagnosis, signaling a strong weight-loss use trend
Notably, semaglutide emerged as the second best-selling drug in 2024, and in the same year, sales of tirzepatide increased 124% from the previous year [2]
These customers want protein packed mini desserts that satisfy their sweet tooth without derailing wellness goals
Moreover, certain medical conditions (such as pernicious anemia) may require to continue receiving injections every month
Should cisapride be avoided in patients with diabetic gastroparesis
Once Mounjaro is started, thyroid function should be reassessed periodically, particularly during the dose escalation phase and after significant weight loss